Figure 2.

Current approaches to Haplo-identical bone marrow transplant. Recent novel strategies include issues of donor selection, ex vivo complete or partial T cell depletion of HPC-M or HPC-A grafts and the use of anti-thymocyte globulin. Additional strategies include in vivo administration of “high dose” cyclophosphamide and intensive multi-agent GVHD prophylaxis. Finally, in an effort to overcome severe prolonged immune suppression the addition of donor T lymphocytes that have been purged of alloreactive T cells may be of benefit. Abbreviations: DSA: Donor-specific antibodies; MLR: Mixed lymphocyte reaction; HLA: Human leukocyte antigen; GVT: Graft-versus tumor; KIR: Killer cell Ig-like receptors; GVHD: Graft-vs-host disease; ATG: Anti-thymocyte globulin.